Estimated antiretroviral therapy coverage among people living with HIV in Europe (WHO region)
Europe (WHO region): Estimated antiretroviral therapy coverage among people living with HIV was 67.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in Europe (WHO region), 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Europe (WHO region) recorded 67.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 3.1% on the previous year and up 45.7% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Europe (WHO region) peaked at 67.0% in 2025 and was at its lowest, 19.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in Europe (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 19.0% | — |
| 2001 | 20.0% | +5.3% |
| 2002 | 22.0% | +10.0% |
| 2003 | 23.0% | +4.5% |
| 2004 | 24.0% | +4.3% |
| 2005 | 25.0% | +4.2% |
| 2006 | 27.0% | +8.0% |
| 2007 | 29.0% | +7.4% |
| 2008 | 31.0% | +6.9% |
| 2009 | 33.0% | +6.5% |
| 2010 | 35.0% | +6.1% |
| 2011 | 37.0% | +5.7% |
| 2012 | 39.0% | +5.4% |
| 2013 | 41.0% | +5.1% |
| 2014 | 44.0% | +7.3% |
| 2015 | 46.0% | +4.5% |
| 2016 | 50.0% | +8.7% |
| 2017 | 54.0% | +8.0% |
| 2018 | 57.0% | +5.6% |
| 2019 | 61.0% | +7.0% |
| 2020 | 63.0% | +3.3% |
| 2021 | 64.0% | +1.6% |
| 2022 | 65.0% | +1.6% |
| 2023 | 66.0% | +1.5% |
| 2024 | 65.0% | -1.5% |
| 2025 | 67.0% | +3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.3% | 19.0% | 33.0% | 10 |
| 2010s | 46.4% | 35.0% | 61.0% | 10 |
| 2020s | 65.0% | 63.0% | 67.0% | 6 |
Countries ranked near Europe (WHO region)
More health data for Europe (WHO region)
- Pertussis - number of reported cases, gaps filled 52,021 (2025)
- Measles - number of reported cases, gaps filled 38,686 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Diphtheria - number of reported cases, gaps filled 199 (2025)
- Total tetanus - number of reported cases, gaps filled 85 (2025)
- Number of infant deaths, annual growth rate -5.46 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.27 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -8.58 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -74.39 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -82.58 % change on previous year (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Europe (WHO region)?
- Estimated antiretroviral therapy coverage among people living with hiv in Europe (WHO region) was 67.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Europe (WHO region)?
- The highest recorded value was 67.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Europe (WHO region)?
- The lowest recorded value was 19.0% in 2000.
- How does Europe (WHO region) rank for estimated antiretroviral therapy coverage among people living with hiv?
- Europe (WHO region) ranks 8th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Europe (WHO region)?
- Over the last ten years it is up 45.7%. The long-run trend across the full record is rising.
- Where does this Europe (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).